Godavari Drugs Ltd EPS

Godavari Drugs Ltd EPS

Image

Godavari Drugs Ltd

NSE: GODAVARIDRUGS

EPS

₹ 4.3

Last updated on: May 04, 2026

Key Highlights

  • The Earning per Share of Godavari Drugs Ltd is ₹ 4.3 as of 04 May 26 The earning per share of Godavari Drugs Ltd changed from ₹ 2.17 to ₹ 1.01 over 6 quarters. This represents a CAGR of -39.94% .

Historical Earning per Share of Godavari Drugs Ltd

No data available

* All values are in

Company Fundamentals for Godavari Drugs Ltd

Market Cap

127 Cr

EPS

4.3

P/E Ratio (TTM)

29.3

P/B Ratio (TTM)

1.9

Day’s High

126.95

Day’s Low

124.0

DTE

1.6

ROE

12.7

52 Week High

132.96

52 Week Low

69.7

ROCE

11.1

Market Price of Godavari Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Godavari Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 May 2026125.8
30 Apr 2026123.32
29 Apr 2026126.4
28 Apr 2026114.53
27 Apr 2026117.98
24 Apr 2026115.31
23 Apr 2026118.51
22 Apr 2026120.05
21 Apr 2026116.98
20 Apr 2026122.04

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Godavari Drugs Ltd

Asset Value vs Market Value of Godavari Drugs Ltd

Market Value

127

Asset Value

Value addition

0.6 X

79

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Godavari Drugs Ltd127.4
Sun Pharmaceutical Industries Ltd437663
Divis Laboratories Ltd175692
Torrent Pharmaceuticals Ltd143909
Cipla Ltd107827
Dr Reddys Laboratories Ltd107500

Historical Market Cap of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Godavari Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Godavari Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Godavari Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Godavari Drugs Ltd News Hub

Godavari Drugs standalone net profit rises 101.23% in the June 2024 quarter

Net profit of Godavari Drugs rose 101.23% to Rs 1.63 crore in the quarter ended June 2024 as against

Read more

14 Aug 24

Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2024. Power

Read more

10 Aug 24

Godavari Drugs standalone net profit rises 26.74% in the September 2024 quarter

Net profit of Godavari Drugs rose 26.74% to Rs 1.09 crore in the quarter ended September 2024 as aga

Read more

14 Nov 24

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024 Powe

Read more

09 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Godavari Drugs Ltd

What is the EPS of Godavari Drugs Ltd stock?

The Earnings Per Share (EPS) of Godavari Drugs Ltd is 4.3. An EPS is the amount of net income attributed to each share of a common stock.

How is Godavari Drugs Ltd EPS calculated?

The EPS of Godavari Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Godavari Drugs Ltd report its EPS?

Godavari Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Godavari Drugs Ltd EPS?

Factors that influence the EPS of Godavari Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Godavari Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Godavari Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions